Monday, November 29, 2021

NEWS

Vietnam to buy 10 million doses of Cuban anti-Covid-19 vaccine

Vietnam to buy 10 million doses of Cuban anti-Covid-19 vaccine

Hanoi, Sep 20 (Prensa Latina) Vietnam decided on Monday to buy Cuba 10 million doses of the anti-Covid-19 vaccine, Abdala (CIGB-66), to be administered in emergency situations, coinciding with President Nguyen Xuan Phuc's visit to the island.
Share on facebook
Share on twitter
Share on whatsapp
Share on telegram
Share on email

A resolution by the Vietnamese Government instructed its Ministry of Health to consummate the transaction and, in coordination with local specialized agencies, to carry out the usual tests to validate the quality of the vaccine, produced by the Havana-based Center for Genetic Engineering and Biotechnology (CIGB).

Cuba also confirmed on Sunday that it will transfer to Vietnam the production technology of Abdala (CIGB-66), one of the three own vaccines used in its vaccination campaign.

Vietnam will thus become the first country outside Cuba to produce this medicine, whose emergency use was approved on Saturday.

On Sunday, also in Havana, Cuba’s Biotechnology and Pharmaceutical Industries Business Group and Vietnam’s Sovico Group sealed a memorandum of understanding to establish alliances in the field of the anti-Covid-19 immunogens and the treatment of chronic non-communicable diseases.

Cuba, the only Latin American country with three of its own anti-Covid-19 vaccines (Abdala (CIGB-66), Soberana 02, Soberana Plus), also has the vaccine candidates, Soberana 01 and Mambisa (CIGB-669). The latter is one of the few globally that is administered nasally.

pgh/iff/mem/asg

RELATED
ÚLTIMO MINUTO
name of Prensa Latina

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

© 2016-2021 Prensa Latina
Latin American News Agency

Radio – Publications  – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado,  Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division  Prensa Latina.